RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
200 hedge funds and large institutions have $430M invested in Revance Therapeutics, Inc. in 2024 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 40 increasing their positions, 54 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
17% less call options, than puts
Call options by funds: $4.42M | Put options by funds: $5.33M
26% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 54
Holders
200
Holding in Top 10
2
Calls
$4.42M
Puts
$5.33M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$21.6M | |
| 3 | +$16.3M | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$13M |
| 5 |
WIC
Water Island Capital
New York
|
+$12.4M |
Top Sellers
| 1 | -$35.8M | |
| 2 | -$18.9M | |
| 3 | -$14.6M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.7M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$10.3M |